Stealth BioTherapeutics' filing for rare disease drug elamipretide has been turned down by the FDA, although the company says the US regulator has given it a "path forward" for the programme.
A well-regulated militia being necessary to the security of a free state. The right of the people to keep and bear arms shall not be infringed. Bearing Arms editor Cam Edwards provides a daily dose of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback